StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines GAAP Diluted Earnings (Loss) per ADS by Quarter

GAAP Diluted Earnings (Loss) per ADS ($/ADS, 1 ADS = 13 Ordinary Shares) ($)

QuarterlyAnnual

BeOne Medicines GAAP Diluted Earnings (Loss) per ADS: $2.05 in Q2 2026, up 144.0% from a year earlier. That is the highest of the 18 quarters on record here.

Latest, Q2 2026
2.05
Period ended Jun 30, 2026
Change on a year earlier
+144.0%
0.84 in Q2 2025
History
18 quarters
Since Q1 2020
Sources
14
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Form 8-K Non-GAAP Reconciliations.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP Diluted Earnings (Loss) per ADS ($/ADS, 1 ADS = 13 Ordinary Shares) ($)Year on yearSource
Q2 2026Jun 30, 20262.05+144.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261.96+19,500.0%Form 10-Q (filed 2026-05-06) ↗
Q3 2025Sep 30, 20251.09-194.8%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20250.84-173.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20250.01-100.4%Form 10-Q (filed 2026-05-06) ↗
Q3 2024Sep 30, 2024-1.15-157.2%Form 10-Q (filed 2025-11-06) ↗
Q2 2024Jun 30, 2024-1.15-68.4%Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 2024-2.41-27.8%Form 10-Q (filed 2025-05-07) ↗
Q3 2023Sep 30, 20232.01-137.3%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023-3.64-33.8%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023-3.34-21.4%Form 10-Q (filed 2024-05-08) ↗
Q3 2022Sep 30, 2022-5.39+14.2%Form 10-Q (filed 2023-11-09) ↗
Q2 2022Jun 30, 2022-5.50+5.2%Form 10-Q (filed 2023-08-02) ↗
Q1 2022Mar 31, 2022-4.25-715.9%Form 10-Q (filed 2023-05-04) ↗
Q3 2021Sep 30, 2021-4.72–Form 10-Q (filed 2022-11-09) ↗
Q2 2021Jun 30, 2021-5.23–Form 10-Q (filed 2022-08-08) ↗

Breakdown

What makes up GAAP Diluted Earnings (Loss) per ADS

Cite this data

StockData. (2026). BeOne Medicines GAAP Diluted Earnings (Loss) per ADS ($), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/eps-ads-diluted

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.